, or tumor necrosis factor-α (TNF-α). HEK 293 cells (ATCC, Manassas, VA, USA) were grown to 90% confluence in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA) and transfected with 0.5 µg plasmid DNA (phRG-TK or phRG-B) using 2 µL LIPOFECTAMINE™ 2000 (Invitrogen) according to the manufacturer's instructions. After 4 h, the cells were washed and treated with the indicated concentrations of 15d-PGJ 2 or a corresponding amount of methyl acetate (MA) carrier, media alone (control), IL-1β (1 ng/mL), or TNF-α (10 ng/mL) in serum-free medium for 20 h. The cells were lysed, and the luciferase activity was measured using the Dual-Luciferase ® Reporter Assay System (Promega). The luciferase activity was normalized to the protein concentration (µg/mL) of the lysate. Data are presented as the mean (× -± SEM) of experiments done in triplicate and are representative of at least three independent experiments. Data were examined for significant differences using analysis of variance (ANOVA), followed by individual comparisons with the Bonferroni post-test. P < 0.05 was considered significant. (A) Dose-dependent effect of 15d-PGJ 2 on phRG-TK activity. *P < 0.05; **P < 0. 
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standard to normalize plate-to-plate variations. For example, the firefly luciferase reporter plasmid pRSV-luc and the native Renilla luciferase reporter plasmid pRL-TK were found to be sensitive to cotransfection with certain nuclear receptors (1, 2) . pRL-TK was also affected by dihydrotestosterone and dexamethasone treatment (3). β-galactosidase reporter vectors were shown to repress platelet-derived growth factor β polypeptide (PDGFB) regulatory element reporter gene expression (4), were sensitive to cotransfection of the Fli-1 transcription factor (5), and were enhanced by angiotensin II (6) . All of these studies suggest that using internal control reporter systems in certain experiments may lead to a misinterpretation of the results.
While investigating the regulation of the interleukin-8 (IL-8) gene promoter by the cyclopentenone prostaglandin 15-deoxy-∆ 12,14 -prostaglandin J 2 (15d-PGJ 2 ) (Cayman Chemical, Ann Arbor, MI, USA), we consistently observed changes in the activity of the secondgeneration Renilla reporter vectors phRG-TK and phRG-B (Promega, Madison, WI, USA), which were used as internal control plasmids for IL-8 promoter constructs. Because these second-generation Renilla vectors were engineered to reduce the risk of anomalous transcriptional behavior (http:// www.promega.com/ tbs/tm237/tm237.pdf), we undertook the present study to formally assess the sensitivity of phRG-TK and phRG-B to 15d-PGJ 2 and the proinflammatory cytokines IL-1β and tumor necrosis factor-α (TNF-α) (both from R&D Systems, Minneapolis, MN, USA).
Here we show that 15d-PGJ 2 dose-dependently inhibited the expression of phRG-TK ( Figure 1A ) and phRG-B ( Figure 1C ), while its solvent, methyl acetate, had little effect ( Figure  1, A and C) . The maximum inhibition of Renilla expression for both vectors (5-to 6-fold) was achieved with concentrations of 15d-PGJ 2 between 7.5 and 10 µM. These 15d-PGJ 2 concentrations were nontoxic, but cellular toxicity characterized by cell shrinkage, development of cytoplasmic vesicles, and detachment from the culture flasks was apparent at concentrations of 15 µM or greater. The inhibition of Renilla expression was stimulusspecific because IL-1β and TNF-α had no significant effect on phRG-TK or phRG-B activity (Figure 1 , B and D, respectively).
To determine whether 15d-PGJ 2 also affected firefly luciferase, firstgeneration Renilla luciferase, and nonluciferase plasmids, we tested the response of pGL3-Basic, pRL-TK, and pSV-β-galactosidase (all from Promega) to the prostaglandin. At concentrations between 7.5 and 10 µM, 15d-PGJ 2 attenuated the expression of pGL3-Basic and pRL-TK by approximately 2-fold (data not shown). Similarly, 15d-PGJ 2 had a small inhibitory effect on pSV-β-galactosidase, with a maximum inhibition of 36% at 10 µM (Figure 2A ). Unexpectedly, IL-1β and TNF-α increased β-galactosidase activity 2.2-to 3.3-fold, respectively ( Figure 2B) .
Presently, there are no known reports that the synthetic second-generation Renilla co-reporter vectors phRG-TK and phRG-B are sensitive to cotransfected plasmids or chemical or cytokine agonists. However, the cyclopentenone prostaglandin 15d-PGJ 2 significantly inhibited the expression of phRG-TK and phRG-B at concentrations that were not cytotoxic to the recipient cells. Although 15d-PGJ 2 also attenuated the expression of the native Renilla vector pRL-TK, the firefly luciferase vector pGL3, and the nonluciferase vector pSV-β-galactosidase, the degree of inhibition was less pronounced than for the synthetic Renilla genes, which suggests vector-specific sensitivity. While these data demonstrate that phRG-TK and phRG-B can respond inappropriately to a specific experimental stimulus in the context of HEK 293 transfection, other stimuli and cell lines will need to be tested to determine the extent of this response.
The precise site of action and mechanism of inhibition of phRG-TK and phRG-B by 15d-PGJ 2 remains unclear. This effect does not appear to be specific for the vectors' promoter sequences because although phRG-TK and phRG-B are both derived from the pGL3-Basic vector backbone, phRG-TK contains the herpes simplex virus thymidine kinase promoter, whereas phRG-B is promoterless. Given the disparity in the degree of prostaglandin-mediated inhibition of pGL3-Basic compared to phRG-TK and phRG-B, it -1β) , or tumor necrosis factor-α (TNF-α). HEK 293 cells were transfected with 0.5 µg of the β-galactosidase vector pSV-β-galactosidase and treated with the indicated concentrations of 15d-PGJ 2 or a corresponding amount of methyl acetate (MA) carrier, media alone (control), IL-1β (1 ng/mL), or TNF-α (10 ng/mL). β-galactosidase activity was measured according to the Promega Protocols and Application Guide (3rd edition) after the cells had been lysed in a buffer containing 40 mM tricine, pH 7.8, 50 mM NaCl, 2 mM EDTA, 1 mM MgSO 4 , 5 mM dithiothreitol (DTT). and 1% Triton ® X-100. β-galactosidase activity was expressed as the value of A 420 , normalized to the protein concentration (mg/mL) of the lysate. Data are presented as the mean (× -± SEM) of experiments done in triplicate and are representative of at least three independent experiments. Data were examined for significant differences using analysis of variance (ANOVA), followed by individual comparisons with the Bonferroni posttest. P < 0.05 was considered significant. (A) Dose-dependent effect of 15d-PGJ 2 on pSV-β-gal. *P < 0.01 versus MA. (B) Effect of IL-1β or TNF-α on pSV-β-gal. *P < 0.001 versus control.
is unlikely that vector backbone confers the major response to 15d-PGJ 2 . This, along with the observation that the native Renilla gene is inhibited less than the synthetic genes, suggest that the re-engineered Renilla luciferase gene may be the source of enhanced sensitivity to 15d-PGJ 2 . Because 15d-PGJ 2 is a natural ligand of peroxisome proliferator activated receptor (PPAR)-γ (7), we scanned the sequences of native and synthetic Renilla genes for potential PPAR-γ binding motifs using either TFSearch (http://www.cbrc.jp/research/db/ TFSEARCH.html) or visual inspection; however, no typical PPAR-γ response elements were found. This does not exclude the participation of PPAR-γ in the inhibitory effect. For example, activated PPAR-γ can compete for limiting amounts of coactivator proteins necessary for certain transcription factors (8) . Altering the availability of a cofactor required for Renilla expression could potentially explain the observed inhibition. Furthermore, 15d-PGJ 2 readily binds protein sulfhydryl groups (9) , and in this way, could directly modify or inactivate cofactors needed for Renilla transcription or translation.
β-galactosidase reporter vectors have been the subject of concern as internal controls in transfection assays because of cross-talk with cotransfected plasmids (4) (5) (6) . Adding to this concern, we found pSV-β-galactosidase expression to be significantly increased by IL-1β or TNF-α treatment. It has been suggested that transfecting β-galactosidase protein may be a better way to monitor transfection efficiency. Assuming a similar transfection efficiency for protein and DNA constructs and acknowledging the potential influence of cell type, by bypassing transcription and translation, this technique should not be affected by transcription factors and inducing agents (10) .
The inclusion of control reporter vectors in transient transfection assays is routine for the determination of transfection efficiencies. The choice of a control vector appears to be a critical factor to avoid potentially misleading results. Strong inhibition of normalization controls may falsely suggest an increase in the activity of test constructs, while up-regulation of internal control activity may artificially blunt true increases. In complicated and varied experimental conditions, we recommend pretesting several control vectors to find one best suited to serve as the internal control for a particular study. As an alternative choice to using control vectors, one could consider normalizing transfection assay results to protein concentration in the cell lysate and performing a larger number of replicates.
